Research Project
Grant-in-Aid for Young Scientists (B)
CD5+ DLBCL shows a poor prognosis and high incidence of central nervous system relapse. By gene expression profiling, we confirmed that most of CD5+ DLBCLs are classified as activated B cell-like DLBCL. A classifier based on gene expression at supervised analysis also correctly identified CD5 expression. The top classifier gene supervised by CD5 expression was SH3BP5. A lot of neurological component-and function-related genes were contained in the CD5 DLBCL signature genes. Immunohistochemical analysis confirmed that SH3BP5 expression was detected on the tumor cell.
All 2011 2010
All Journal Article (5 results) (of which Peer Reviewed: 3 results) Presentation (15 results) Book (2 results)
Ann Oncol
Volume: 22 Pages: 1601-1607
血液内科
Volume: 63 Pages: 34-39
Volume: 22 Issue: 7 Pages: 1601-1607
10.1093/annonc/mdq627
Annals of Oncology
Volume: (in press)
血液フロンティア
Volume: 20 Pages: 1009-1015